PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·562 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 20 epsHosts
Not detected.
Recent guests
Recent episodes
Neal D. Shore, MD, FACS - Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care
Jun 15, 2026
Unknown duration
Amy Goodrich, CRNP - Patient–Nurse Partnerships in CLL: Making the Most of Targeted Standard of Care Options
Jun 15, 2026
Unknown duration
Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes
Jun 5, 2026
31m 52s
Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies
Jun 4, 2026
1h 05m 50s
Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings
May 29, 2026
54m 53s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/15/26 | Neal D. Shore, MD, FACS - Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WXE865. CME/AAPA/IPCE credit will be available until June 16, 2027.Maximizing NMIBC Outcomes: Personalized, Risk-Adapted Approaches With Intravesical Therapy and Collaborative Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/15/26 | Amy Goodrich, CRNP - Patient–Nurse Partnerships in CLL: Making the Most of Targeted Standard of Care Options | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete NCPD/ILNA information, and to apply for credit, please visit us at PeerView.com/QHK865. NCPD/ILNA credit will be available until June 12, 2027.Patient–Nurse Partnerships in CLL: Making the Most of Targeted Standard of Care Options In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AstraZeneca and BeOne Medicines.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/5/26 | Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes✨ | Polycythemia VeraHepcidin Pathway+3 | Andrew Kuykendall, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Polycythemia VeraHepcidin+5 | Takeda Pharmaceuticals U.S.A., Inc. | 31m 52s | |
| 6/4/26 | Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies✨ | immunotherapyNSCLC+4 | Brendon M. Stiles, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | Rahway, NJ, USA | immunotherapyNSCLC+6 | AstraZeneca | 1h 05m 50s | |
| 5/29/26 | Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings✨ | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Jaume Capdevila, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 54m 53s | |
| 5/29/26 | Ibrahim Aldoss, MD - Expanding Bispecific Options for Acute Lymphoblastic Leukemia: From Current Standards to Future Practice✨ | Acute Lymphoblastic LeukemiaBispecific Options+3 | Ibrahim Aldoss, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Acute Lymphoblastic Leukemiabispecific therapy+4 | AstraZeneca | 37m 51s | |
| 5/29/26 | Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans✨ | advanced ovarian cancerpersonalized treatment plans+3 | Bhavana Pothuri, MD, MSPremal Thaker, MD, MS | PVI, PeerView Institute for Medical EducationNational Ovarian Cancer Coalition+3 | — | ovarian cancertargeted therapy+5 | GSK | 51m 15s | |
| 5/29/26 | Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients✨ | Asparaginase ExposurePersonalized Treatment+3 | Luke Maese, DORachel Rau, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | AsparaginasePediatric Oncology+5 | Jazz Pharmaceuticals | 48m 37s | |
| 5/29/26 | Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy✨ | Oncology NursingImmunotherapy+3 | Charise GleasonBeth Faiman | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | RRMMBCMA+4 | GSK | 59m 51s | |
| 5/29/26 | Amy E. Armstrong, MD, Angela Hirbe, MD, PhD - ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models✨ | NF1-PNMEK Inhibition+3 | Amy E. Armstrong, MDAngela Hirbe, MD, PhD | PeerView Institute for Medical EducationNeurofibromatosis Network | — | NF1-PNMEK Inhibition+3 | Alexion | 1h 05m 17s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 5/13/26 | Jason Westin, MD, MS, FACP, FASCO - Raising the CAP on Lymphoma Care: Community–Aligned Principles for Integrating CELMoDs Into Real-World Practice✨ | Lymphoma CareCELMoDs+3 | Jason Westin, MD, MS, FACP, FASCOJason Westin | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | LymphomaCELMoDs+5 | Bristol Myers Squibb | 37m 19s | |
| 5/12/26 | Amandeep Salhotra, MD - An Immune Reset for AlloHCT Recipients: Updates on Engineered Cell Therapy for Improving Transplant Outcomes and Reducing GVHD✨ | AlloHCTEngineered Cell Therapy+3 | Amandeep Salhotra, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | AlloHCTGVHD+5 | Orca Bio | 28m 41s | |
| 5/12/26 | Eileen M. O'Reilly, MD, FASCO - Redefining Precision Oncology in Pancreatic Cancer: Translating Emerging KRAS-Targeted Strategies into Effective Clinical Management | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UEH865. CME/AAPA/IPCE credit will be available until April 21, 2027.Redefining Precision Oncology in Pancreatic Cancer: Translating Emerging KRAS-Targeted Strategies into Effective Clinical Management In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Revolution Medicines.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 5/7/26 | Tiba Al Sagheer, PharmD, BCOP, BCACP, Amanda Yepes, PharmD, BCOP - Coordinating Transformative Care in NHL: Pharmacist Insights for Delivering CAR-T Therapy in the Era of Expanded Access and Therapeutic Innovation✨ | NHLCAR-T Therapy+4 | Tiba Al Sagheer, PharmD, BCOP, BCACPAmanda Yepes, PharmD, BCOP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | NHLCAR-T Therapy+5 | Bristol Myers Squibb | 1h 00m 30s | |
| 5/7/26 | David Sabatino, PharmD, BCOP / Marie E. Sirek, PharmD, BCACP, CPP - B-Keepers: Pharmacist Principles for Effective BTK Targeting in CLL, MCL, and Other B-Cell Cancers✨ | pharmacist principlesBTK targeting+4 | David Sabatino, PharmD, BCOPMarie E. Sirek, PharmD, BCACP, CPP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | BTK inhibitorschronic lymphocytic leukemia+4 | AstraZeneca | 57m 33s | |
| 4/28/26 | Justin Arnall, PharmD, FCCP, BCOP / Anthony J. Perissinotti, PharmD, BCOP - Dispensing High-Quality Care for Myelofibrosis: Pharmacist Leadership in Delivering Effective JAKi Therapy✨ | MyelofibrosisPharmacist Leadership+3 | Justin Arnall, PharmD, FCCP, BCOPAnthony J. Perissinotti, PharmD, BCOP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | MyelofibrosisJAKi Therapy+4 | GSK | 57m 16s | |
| 4/27/26 | Guy Young, MD - Driving Innovation Forward in Hemophilia B With Gene Therapy: Clinical Conversations on Progress and Guidance on Practical Delivery✨ | Hemophilia BGene Therapy+3 | Guy Young, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Hemophilia BGene Therapy+4 | CSL Behring | 53m 29s | |
| 4/27/26 | Carl M. Gay, MD, PhD / Shelby L. Quinn, PharmD, BCOP - The 3 P’s of Pharmacist-Focused Care for DLL3-Targeting T-Cell Engagers in ES-SCLC: Plans, Protocols, and Patient Education✨ | Pharmacist-Focused CareDLL3-Targeting T-Cell Engagers+3 | Carl M. Gay, MD, PhDShelby L. Quinn, PharmD, BCOP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | pharmacist careDLL3+4 | Amgen | 54m 41s | |
| 4/27/26 | Sarah Hayward, PharmD, BCOP - Putting Pharmacist-Led Solutions Into Practice for Endometrial and Ovarian Cancer Care: Integrating Modern Therapies Into Personalized Treatment✨ | pharmacist-led solutionsendometrial cancer care+4 | Sarah Hayward | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | Rahway, NJ, USA | pharmacist-led solutionsendometrial cancer+7 | AstraZeneca | 1h 04m 37s | |
| 4/27/26 | Ross Soo, MBBS, PhD, FRACP / Jonathan D. Spicer, MD, PhD, FRCSC - The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC✨ | personalized medicineEGFRm NSCLC+3 | Ross Soo, MBBS, PhD, FRACPJonathan D. Spicer, MD, PhD, FRCSC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | EGFR mutationNSCLC+3 | AstraZeneca | 40m 08s | |
| 4/27/26 | Shambavi Richard, MD / Joshua Richter, MD, FACP - Sorting the Sequence in Multiple Myeloma: Personalized Choices With BCMA and Non-BCMA Immunotherapies in Relapsed/Refractory Disease✨ | Multiple MyelomaImmunotherapies+3 | Shambavi Richard, MDJoshua Richter, MD, FACP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Multiple MyelomaBCMA+5 | Arcellx, Inc. | 53m 21s | |
| 4/15/26 | Krish Patel, MD / Nirav Shah, MD, MS - Adapting to Innovation in B-Cell Cancers: Advances With Targeted Therapy and CAR-T and Revisiting the Role of Transplant✨ | B-Cell CancersTargeted Therapy+4 | Krish Patel, MDNirav Shah, MD, MS | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | B-Cell CancersTargeted Therapy+5 | AstraZeneca | 58m 28s | |
| 4/15/26 | Olalekan Oluwole, MBBS, MPH - ChARTing New Ground in NHL: Practice-Changing Evidence, Real-World Experience, and Outpatient Delivery of Cellular Therapy✨ | Non-Hodgkin LymphomaCellular Therapy+3 | Olalekan Oluwole, MBBS, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Non-Hodgkin Lymphomacellular therapy+5 | Bristol Myers Squibb | 1h 00m 56s | |
| 4/15/26 | Haydar Frangoul, MD, MS, Akshay Sharma, MBBS, MSc - Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD and Thalassemia | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/WYB865. CME/NCPD/AAPA credit will be available until April 12, 2027.Transformative Care for Hemoglobinopathies: Guidance on the Gene Therapy Experience in SCD & Thalassemia In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Beam Therapeutics and Vertex Pharmaceuticals.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 4/3/26 | Tanios Bekaii-Saab, MD, FACP, FASCO - Raising the Game in Biliary Cancer: Adapting Rapidly Emerging Evidence and Achieving Optimal Disease Control With FGFR-Targeted Platforms | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ACV865. CME credit will be available until March 31, 2027.Raising the Game in Biliary Cancer: Adapting Rapidly Emerging Evidence and Achieving Optimal Disease Control With FGFR-Targeted Platforms In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Incyte Corporation.Disclosure information is available at the beginning of the video presentation. | — | ||||||
Showing 25 of 583
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.